Biotech · Private company
Jiangsu Yahong Meditech Co., Ltd aka Asieris
Track this companyFree. Adds Jiangsu Yahong Meditech Co., Ltd aka Asieris to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- APL-1202 in combination with tislelizumabPhase 2 · Muscle Invasive Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- Tislelizumab alonePhase 2 · Muscle Invasive Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- APL-1401Phase 1 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative ColitisPHASE1 · UNKNOWN · started Jan 26, 2023ClinicalTrials.gov NCT05743010 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder CancerPHASE1_PHASE2 · UNKNOWN · started Dec 28, 2021ClinicalTrials.gov NCT04813107 · fetched Nov 12, 2026